Analysts predict that Mettler-Toledo International, Inc. (NYSE:MTD) will report $763.81 million in sales for the current fiscal quarter, according to Zacks. Six analysts have issued estimates for Mettler-Toledo International’s earnings, with the highest sales estimate coming in at $774.00 million and the lowest estimate coming in at $753.00 million. Mettler-Toledo International posted sales of $709.70 million during the same quarter last year, which would indicate a positive year over year growth rate of 7.6%. The business is expected to issue its next quarterly earnings results on Thursday, February 1st.
According to Zacks, analysts expect that Mettler-Toledo International will report full year sales of $763.81 million for the current year, with estimates ranging from $2.70 billion to $2.72 billion. For the next fiscal year, analysts anticipate that the business will post sales of $2.89 billion per share, with estimates ranging from $2.85 billion to $2.91 billion. Zacks’ sales calculations are a mean average based on a survey of sell-side analysts that follow Mettler-Toledo International.
Mettler-Toledo International (NYSE:MTD) last announced its quarterly earnings data on Thursday, November 2nd. The medical instruments supplier reported $4.36 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $4.32 by $0.04. The company had revenue of $698.80 million during the quarter, compared to analysts’ expectations of $685.56 million. Mettler-Toledo International had a net margin of 16.44% and a return on equity of 96.81%. The firm’s revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.89 EPS.
Shares of Mettler-Toledo International (MTD) opened at $624.67 on Tuesday. The firm has a market cap of $15,980.00, a price-to-earnings ratio of 36.88, a price-to-earnings-growth ratio of 2.85 and a beta of 1.09. The company has a current ratio of 1.51, a quick ratio of 1.11 and a debt-to-equity ratio of 2.05. Mettler-Toledo International has a 12-month low of $408.97 and a 12-month high of $694.48.
In other Mettler-Toledo International news, insider Oliver A. Filliol sold 15,000 shares of the firm’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $631.51, for a total transaction of $9,472,650.00. Following the completion of the sale, the insider now directly owns 31,279 shares in the company, valued at approximately $19,753,001.29. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Michael A. Kelly sold 3,384 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $638.24, for a total transaction of $2,159,804.16. Following the sale, the director now owns 4,762 shares of the company’s stock, valued at $3,039,298.88. The disclosure for this sale can be found here. Over the last quarter, insiders sold 39,969 shares of company stock valued at $25,242,999. 5.20% of the stock is owned by company insiders.
A number of large investors have recently added to or reduced their stakes in MTD. Koch Industries Inc. boosted its holdings in shares of Mettler-Toledo International by 96,281.2% in the second quarter. Koch Industries Inc. now owns 696,836 shares of the medical instruments supplier’s stock worth $696,000 after buying an additional 696,113 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Mettler-Toledo International by 5,926.9% in the second quarter. Janus Henderson Group PLC now owns 202,927 shares of the medical instruments supplier’s stock worth $119,430,000 after buying an additional 199,560 shares during the last quarter. Parametric Portfolio Associates LLC boosted its holdings in shares of Mettler-Toledo International by 253.5% in the second quarter. Parametric Portfolio Associates LLC now owns 201,137 shares of the medical instruments supplier’s stock worth $118,377,000 after buying an additional 144,245 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. purchased a new position in shares of Mettler-Toledo International in the second quarter worth approximately $71,233,000. Finally, BlackRock Inc. boosted its holdings in shares of Mettler-Toledo International by 6.4% in the second quarter. BlackRock Inc. now owns 1,860,178 shares of the medical instruments supplier’s stock worth $1,094,791,000 after buying an additional 112,029 shares during the last quarter. Institutional investors and hedge funds own 91.76% of the company’s stock.
WARNING: “Analysts Expect Mettler-Toledo International, Inc. (MTD) Will Post Quarterly Sales of $763.81 Million” was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another publication, it was illegally stolen and reposted in violation of United States & international trademark and copyright laws. The legal version of this piece of content can be viewed at https://www.americanbankingnews.com/2017/12/12/analysts-expect-mettler-toledo-international-inc-mtd-will-post-quarterly-sales-of-763-81-million.html.
About Mettler-Toledo International
Mettler-Toledo International Inc is a supplier of precision instruments and services. The Company operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations and Other. The Company manufactures weighing instruments for use in laboratory, industrial, packaging, logistics and food retailing applications.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Mettler-Toledo International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.